DINESH B. PATEL & ORS. versus STATE OF GUJARAT & ORS.
Open in Lexace · Ask the AI about this caseJudgment (excerpt)
[2010] 10 S.C.R. 319 DINESH 8. PATEL & ORS. v. STATE OF GUJARAT & ORS. (Criminal Appeal No. 1464 of 2010) AUGUST 6, 2010 [V.S. SIRPURKAR AND CYRIAC JOSEPH, JJ.] A B Code of Criminal Procedure, 1973 - s. 482 - Criminal complaint - Against a Company, which manufactured medicines, and its Directors - Alleging defect in the C manufactured medicines - Petition for quashing the complaint - Dismissed by High Court - On appeal, held: Complaint not liable to be quashed - The complaint suggested that the Directors were privy to the manufacturing of medicine by the Company - Allegations were serious in .D nature - It is open to the Directors to show before trial court that they were not liable u/s. 34(2) of Drugs and Cosmetics Act - Drugs and Cosmetics Act, 1940 - s. 34(2). A compliant was filed against a medicine manufacturing Company and its Directors, alleging defect E in the medicines manufactured. The Company :and ·the Directors filed petition u/s. 482 Cr.P.C. seeking quashing of the complaint. High Court dismissed the petition holding that all the Directors were liable to be prosecuted and the complaints against them could not be disposed F of u/s. 482 Cr.P.C., as it required appreciation ofthe facts on the basis of evidence to be led before the trial·court. Therefore, the Company and the Directors approached Supreme Court. The Court dismissed the SL:.P as regards the Managing Director. Notice was issued in respect of G the other appellants. Dismissing the appeal, the Court 319 H 320 SUPREME COURT REPORTS (2010] 10 S.C.R. A HELD: 1. The respondent-Directors of the Company were not arrayed only because they were the Directors. In addition to that, a statement has been i;nade in the complaint that by manufacturing of the concerned medicine for sale, the Company and its Directors had , a committed the breach of the Drugs and Cosmetics Act. Thus, there was an allegation that the Directors were privy to the manufacturing of medicine by the Company. The averments in the complaint cannot be described as bald statements. The complaint suggests manufacturing of the c medicine by the Company and its Directors. The instant case was the case of manufacture of the drug for human consumption and, after it was tested in laboratory, was found to be defective since there was a growth of fungus, which is a very serious matter related to public health. 0 [Paras 7 and 8] [324-D-H; 325-A-B] E F State of Haryana vs. Brij lat Mittal and Ors. 1998 (5) SCC · 343, distinguished. 2. Under the peculiar circumstances of the instant case and in view of the seriousness of the allegations, a technical view cannot be taken. "the logic, in the law laid down in complaint cases u/s~ 138 of the Negotiable Instruments Act requiring specific averment about the active role of the Directors in running the Company, would not apply in the instant case. Firstly, the lpnguage of Section .34(2) of the Drugs and Cosmetics Act substantially differs from the language of Section 141 of the Negotiable Instruments Act. Secondly, the instant case relates to the offence which has the direct impact G on the public health. Therefore, the o~der of the High Court is not interfered with. It will be open'for the Directors to show to the trial court that they had nothing to do with the manufacture process and, therefor~, they should not be held liable u/s. 34(2) of the DruglS and H Cosmetics Act. [Para 9] [325-B-E] DINESH B. PATEL & ORS. v. STATE OF GUJARAT &321 ORS. Case Law Reference: 1998 (5) sec 343 Distinguished. Para 4 CRIMINAL APPELLATE JURISDICTION : Criminal Appeal No. 1464 of 2010. From the Judgment & Order dated 29.07.2008 of the High Court of Gujarat at Ahmadabad in Criminal Misc. Application No. 5711 of 2008. H.A. Raichura for the Appellants. K. Enatoli Serna (for Hemantika Wahi) for the Respondents. The Judgment of the Court was delivered by V.S. SIRPURKAR, J. 1. Leave granted. 2. The present appeal challenges the order of the High Court whereby the petition under Section 482 Cr.P.C. filed by A B c D the company and its directors (appellants herein) was dismissed by the High Court. The High Court took the view that E the directors are responsible for the affairs of the company and, therefore, when a drug manufactured by the company was found to be defective, all the directors could be prosecuted. The · High Court, however, left it to the concerned parties to pro
Excerpt shown. Read the full judgment & AI analysis in Lexace.
Lex